Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-04

Clinical Trial Update: NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission [Phase 3]

View source ↗

Summary

Phase 3 trial comparing NNRTI versus protease inhibitor regimens for HIV-infected women after nevirapine exposure for prevention of mother-to-child transmission…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-02-04